Figure 3 depicts the growth of in-hospital, off-label uses of rFVIIa
in Premier database for hemophilia, ICH, trauma, liver transplant, CV
surgery, prostatectomy, and other uses. The x axis starts at 0
hospitalizations and ends at 8,000. The y axis shows years from 2000 to
2008. The line graph shows the most change in all other off label
uses.

Figure 3Growth of in-hospital, off-label vs. on-label uses of rFVIIa in Premier database

From: Results

Cover of Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care
Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care [Internet].
Comparative Effectiveness Reviews, No. 21.
Yank V, Tuohy CV, Logan AC, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.